Immunotherapy of tuberculosis with Mycobacterium leprae HSP65 as a DNA vaccine triggers cross-reactive antibodies against mammalian Hsp60 but not pathological autoimmunity (2014)
- Authors:
- USP affiliated authors: RIOS, WENDY MARTIN - FMRP ; FLORIANO, ELAINE MEDEIROS - FMRP ; BRANDAO, IZAIRA TINCANI - FMRP ; RAMOS, SIMONE GUSMÃO - FMRP ; SILVA, CELIO LOPES - FMRP
- Unidade: FMRP
- DOI: 10.4161/hv.28249
- Subjects: TUBERCULOSE; IMUNIZAÇÃO; VACINAS; IMUNOTERAPIA
- Language: Inglês
- Imprenta:
- Source:
- Título: Human Vaccines and Immunotherapeutics
- ISSN: 2164-5515
- Volume/Número/Paginação/Ano: v. 10, n. 5, p. 1238-1243, 2014
- Status:
- Artigo possui acesso gratuito no site do editor (Bronze Open Access)
- Versão do Documento:
- Versão publicada (Published version)
- Acessar versão aberta:
-
ABNT
DOIMO, Nayara T. S. et al. Immunotherapy of tuberculosis with Mycobacterium leprae HSP65 as a DNA vaccine triggers cross-reactive antibodies against mammalian Hsp60 but not pathological autoimmunity. Human Vaccines and Immunotherapeutics, v. 10, n. 5, p. 1238-1243, 2014Tradução . . Disponível em: https://doi.org/10.4161/hv.28249. Acesso em: 04 abr. 2026. -
APA
Doimo, N. T. S., Zárate-Bladés, C. R., Rodrigues, R. F., Tefé-Silva, C., Trotte, M. N. S., Souza, P. R. M., et al. (2014). Immunotherapy of tuberculosis with Mycobacterium leprae HSP65 as a DNA vaccine triggers cross-reactive antibodies against mammalian Hsp60 but not pathological autoimmunity. Human Vaccines and Immunotherapeutics, 10( 5), 1238-1243. doi:10.4161/hv.28249 -
NLM
Doimo NTS, Zárate-Bladés CR, Rodrigues RF, Tefé-Silva C, Trotte MNS, Souza PRM, Soares LS, Rios WM, Floriano EM, Brandão IT, Masson AP, Coelho V, Ramos SG, Silva CL. Immunotherapy of tuberculosis with Mycobacterium leprae HSP65 as a DNA vaccine triggers cross-reactive antibodies against mammalian Hsp60 but not pathological autoimmunity [Internet]. Human Vaccines and Immunotherapeutics. 2014 ; 10( 5): 1238-1243.[citado 2026 abr. 04 ] Available from: https://doi.org/10.4161/hv.28249 -
Vancouver
Doimo NTS, Zárate-Bladés CR, Rodrigues RF, Tefé-Silva C, Trotte MNS, Souza PRM, Soares LS, Rios WM, Floriano EM, Brandão IT, Masson AP, Coelho V, Ramos SG, Silva CL. Immunotherapy of tuberculosis with Mycobacterium leprae HSP65 as a DNA vaccine triggers cross-reactive antibodies against mammalian Hsp60 but not pathological autoimmunity [Internet]. Human Vaccines and Immunotherapeutics. 2014 ; 10( 5): 1238-1243.[citado 2026 abr. 04 ] Available from: https://doi.org/10.4161/hv.28249 - Evaluation of the overall IFN-γ and IL-17 pro-inflammatory responses after DNA therapy of tuberculosis
- Synergy of chemotherapy and immunotherapy revealed by a genome-scale analysis of murine tuberculosis
- Avaliação de resposta autoimune durante a imunoterapia com DNAhsp65 da tuberculose
- P2×7 purinergic signaling in dilated cardiomyopathy induced by auto-immunity against muscarinic M2 receptors: autoantibody levels, heart functionality and cytokine expression
- Immunization with plasmids encoding M2 acetylcholine muscarinic receptor epitopes impairs cardiac function in mice and induces autophagy in the myocardium
- Protective efficacy of different strategies employing Mycobacterium leprae heat-shock protein 65 against tuberculosis
- Interference of doxycycline pretreatment in a model of abdominal aortic aneurysms
- Response to the “Letter regarding Interference of doxycycline pretreatment in a model of abdominal aortic aneurysms” [Carta]
- Interference of dexamethasone in the pulmonary cycle of Strongyloides venezuelensis in rats
- Host kinin B1 receptor plays a protective role against melanoma progression
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
Por se tratar de integração com serviço externo, podem existir diferentes versões do trabalho (como preprints ou postprints), que podem diferir da versão publicada.
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
